Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.

Radiat Oncol · 2011 · PMC3161863 · PMID 21794119

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

showed a trend favouring gemcitabine (53 vs 61 patients) based CRT [ 42 ] and Li et al. reported a statistically significant survival advantage for patients treated with gemcitabine concurrently to radiotherapy over those treated with 5-fluorouracil (16 vs 18 patients) [ 43 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.